Effect of Vibration Capsule on Different Subtypes of Functional Constipation

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChanghai Hospital

About this trial

This study is a multi-center prospective cohort study, which plans to include 600 patients with chronic functional constipation to treat with Vibrabot capsules and patients will be grouped according to subtypes.

During the study, the patients' basic information, baseline constipation status and treatment information, capsule intake during treatment, and concomitant medication will be collected. During the treatment phase, patients follow the doctor's advice to receive Vibrabot capsule treatment and maintain stable dietary intake and exercise according to the constipation diagnosis and treatment guidelines.

During the study, patients need to fill in the relevant information during the treatment in the electronic questionnaire in a timely and truthful manner. The treatment effect of the patients is evaluated by assessing the number of occurrences of spontaneous bowel movements (SBM) and complete spontaneous bowel movements (CSBM).

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Vibrabot capsule

Treatment groups

600 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Changhai Hospital

Lead sponsor

Ruijin Hospital

Collaborator

Shanghai Tongji Hospital, Tongji University School of Medicine

Collaborator

Shanghai 10th People's Hospital

Collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborator

Shanghai 6th People's Hospital

Collaborator

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Collaborator

Shanghai Pudong New Area Gongli Hospital

Collaborator